Cosmo Pharmaceuticals
C43.F
#5254
Rank
NZ$2.00 B
Marketcap
$122.21
Share price
0.00%
Change (1 day)
78.89%
Change (1 year)

EPS for Cosmo Pharmaceuticals (C43.F)

EPS in 2022: $1.91

According to Cosmo Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $1.91. In 2022 the company made an earnings per share (EPS) of $1.91 a decrease over its 2021 EPS that were of $2.48.

EPS history for Cosmo Pharmaceuticals from 2004 to 2022

Annual EPS

Year EPS Change
2022$1.91-22.92%
2021$2.48-317.03%
2020-$1.14-64.08%
2019-$3.1836.19%
2018-$2.34-47.81%
2017-$4.48-282.25%
2016$2.46-92.5%
2015$32.75209.32%
2014$10.59-6.29%
2013$11.30255.93%
2012$3.17173.6%
2011$1.16107.49%
2010$0.56-22.27%
2009$0.72-55.54%
2008$1.627392.2%
2007$0.02160-124.39%
2006-$0.08855-113.4%
2005$0.66-129.97%
2004-$2.21